A new preprint was uploaded on November 7, 2022 entitled: “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” by a ‘non-conflicted group of researchers’ from… Acuitas? Wait, what?
… Acuitas is the Canadian Biotech company that makes the proprietary Pfizer/BioNTech LNPs.
… the paper reveals some very interesting things, primarily age-related immune modulation induced by empty LNPs (eLNPs). The adjuvant effect of LNPs was always known but exactly how the adjuvant effect operates is still being elucidated.